Characteristics and significance of colorectal cancer associated lymphoid reaction

International Journal of Cancer

Volumn 134, Issue 9, 2014, Pages 2126-2135

  Väyrynen, Juha P ^a,b   Sajanti, Sara A ^a,b   Klintrup, Kai ^a,b,c   Mäkelä, Jyrki ^a,b   Herzig, Karl Heinz ^a,b   Karttunen, Tuomo J ^a,b   Tuomisto, Anne ^a,b   Mäkinen, Markus J ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c MEDICAL RESEARCH CENTER OULU   (Finland)

Author keywords

colorectal cancer; prognosis; T lymphocyte; tertiary lymphoid organ; tumor immunology

Indexed keywords

CD83 ANTIGEN;

ADAPTIVE IMMUNITY; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CROHN LIKE LYMPHOID REACTION; DENDRITIC CELL; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PARAMETERS; IMMUNOPATHOLOGY; INFLAMMATORY CELL; KLINTRUP MAKINEN SCORE; LYMPH FOLLICLE; LYMPHOCYTIC INFILTRATION; LYMPHOID AGGREGATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SCORING SYSTEM;

COLORECTAL CANCER; PROGNOSIS; T LYMPHOCYTE; TERTIARY LYMPHOID ORGAN; TUMOR IMMUNOLOGY;

AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TISSUE ARRAY ANALYSIS;

EID: 84896694750     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28533     Document Type: Article

References (43)

1. Cyster JG,. Lymphoid organ development and cell migration. Immunol Rev 2003; 195: 5-14.
2. Aloisi F, Pujol-Borrell R,. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6: 205-17.
3. Schreiber RD, Old LJ, Smyth MJ,. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-70.
4. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74.
5. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
6. Roxburgh CS, McMillan DC,. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 2012; 38: 451-66.
7. Klintrup K, Mäkinen JM, Kauppila S, et al. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005; 41: 2645-54.
8. Roxburgh CS, Salmond JM, Horgan PG, et al. Tumour inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer. Eur J Cancer 2009; 45: 2138-45.
9. Ogino S, Nosho K, Irahara N, et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res 2009; 15: 6412-20.
10. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353: 2654-66.
11. Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4.
12. Väyrynen JP, Vornanen JO, Sajanti S, et al. An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Arch 2012; 460: 455-65.
13. Galon J, Pages F, Marincola FM, et al. Cancer classification using the immunoscore: a worldwide task force. J Transl Med 2012; 10: 205.
14. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008; 26: 4410-7.
15. Graham DM, Appelman HD,. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 1990; 3: 332-5.
16. Harrison JC, Dean PJ, el-Zeky F, et al. From dukes through jass: pathological prognostic indicators in rectal cancer. Hum Pathol 1994; 25: 498-505.
17. Adams WJ, Morris DL,. Pilot study-cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer 1997; 80: 15-21.
18. Murphy J, O'Sullivan GC, Lee G, et al. The inflammatory response within dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. Am J Gastroenterol 2000; 95: 3607-14.
19. Buckowitz A, Knaebel HP, Benner A, et al. Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases. Br J Cancer 2005; 92: 1746-53.
20. Smyrk TC, Watson P, Kaul K, et al. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 2001; 91: 2417-22.
21. Alexander J, Watanabe T, Wu TT, et al. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol 2001; 158: 527-35.
22. Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas: well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003; 27: 563-70.
23. Hörkkö TT, Klintrup K, Mäkinen JM, et al. Budding invasive margin and prognosis in colorectal cancer-no direct association with beta-catenin expression. Eur J Cancer 2006; 42: 964-71.
24. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
25. Väyrynen JP, Vornanen J, Tervahartiala T, et al. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int J Cancer 2012; 131: E463-74.
26. Kantola T, Klintrup K, Väyrynen JP, et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 2012; 107: 1729-36.
27. Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002; 197: 20-7.
28. Kraus S, Arber N,. Inflammation and colorectal cancer. Curr Opin Pharmacol 2009; 9: 405-10.
29. Hamilton SR, Vogelstein B, Kudo S, et al. Carsinoma of the colon and rectum. In:, Hamilton SR, Aaltonen LA, eds. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000. 103-43.
30. Tuppurainen K, Mäkinen JM, Junttila O, et al. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer. J Pathol 2005; 207: 285-94.
31. Abramoff MD, Magelhaes PJ, Ram SJ,. Image processing with ImageJ. Biophotonics Int 2004; 11: 36-42.
32. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
33. Suzuki A, Masuda A, Nagata H, et al. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 2002; 196: 37-43.
34. Fridman WH, Pages F, Sautes-Fridman C, et al. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 2012; 12: 298-306.
35. Boland CR, Goel A,. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138: 2073-2087.e3.
36. Schwitalle Y, Kloor M, Eiermann S, et al. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 2008; 134: 988-97.
37. Simpson JA, Al-Attar A, Watson NF, et al. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer. Gut 2010; 59: 926-33.
38. Pages F, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010; 29: 1093-102.
39. Zlobec I, Steele R, Terracciano L, et al. Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer. J Clin Pathol 2007; 60: 1112-6.
40. Zlobec I, Lugli A,. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 2009; 15: 5898-906.
41. Pierik M, De Hertogh G, Vermeire S, et al. Epithelioid granulomas, pattern recognition receptors, and phenotypes of crohn's disease. Gut 2005; 54: 223-7.
42. Sewell GW, Marks DJ, Segal AW,. The immunopathogenesis of crohn's disease: a three-stage model. Curr Opin Immunol 2009; 21: 506-13.
43. Adams DO,. The granulomatous inflammatory response. A review. Am J Pathol 1976; 84: 164-92.